(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.08%.
Korro Bio's earnings in 2026 is -$117,260,000.On average, 12 Wall Street analysts forecast KRRO's earnings for 2026 to be -$118,364,598, with the lowest KRRO earnings forecast at -$251,445,987, and the highest KRRO earnings forecast at -$75,415,624. On average, 9 Wall Street analysts forecast KRRO's earnings for 2027 to be -$113,358,524, with the lowest KRRO earnings forecast at -$244,096,245, and the highest KRRO earnings forecast at -$45,128,225.
In 2028, KRRO is forecast to generate -$110,553,333 in earnings, with the lowest earnings forecast at -$246,781,728 and the highest earnings forecast at -$43,159,544.